Displaying 1 - 1 of 1
| Active Ingredient | ETOPOSIDE |
| Therapeutic Class | ANTINEOPLASTICS |
| Indications | Small cell carcinoma of the bronchus, the lymphomas and testicular cancer. |
| Caution | Alopecia; bone-marrow supp ression. |
| Dose Range | Adult: Orally , 120–240 mg/m2 daily for 5 days. |
| Drug Interactions | |
| Pregnancy | Etoposide may cause fetal harm when administered to pregnant women, but potentia More ... |
| Breast Feeding | Unknown. Breastfeeding is not recommended. |